Rafferty Asset Management, LLC Annexon, Inc. Transaction History

Rafferty Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$2.73 - $11.94 $195,689 - $855,871	-71,681 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$11.49 - $22.0 $823,614 - $1.58 Million	71,681 New	71,681 $824,000
Q3 2021 Nov 10, 2021	SELL	$16.35 - $23.4 $453,123 - $648,507	-27,714 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$17.81 - $27.48 $69,672 - $107,501	3,912 Added 16.44%	27,714 $624,000
Q1 2021 May 10, 2021	BUY	$22.0 - $35.01 $523,644 - $833,308	23,802 New	23,802 $663,000

156

101M

3.73M

1.3M

Ticker ANNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,617,700
Market Cap $335M
Description
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Rafferty Asset Management, LLC with notifications on news.